NovaBridge Biosciences

NovaBridge Biosciencesverified

NBP

Price:

$3.99

Market Cap:

$3.25B

NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor. The company also has collaborations with Bristol Myers Squibb for the development...[Read more]

Industry

Biotechnology

IPO Date

2020-01-17

Stock Exchange

NASDAQ

Ticker

NBP

The ROE as of December 2025 (TTM) for NovaBridge Biosciences (NBP) is -18.77%

According to NovaBridge Biosciences’s latest financial reports and current stock price. The company's current ROE is -18.77%. This represents a change of 310.43% compared to the average of -4.57% of the last 4 quarters.

NovaBridge Biosciences (NBP) Historical ROE (quarterly & annually)

How has NBP ROE performed in the past?

The mean historical ROE of NovaBridge Biosciences over the last ten years is -9.64%. The current -18.77% ROE has changed 94.73% with respect to the historical average. Over the past ten years (40 quarters), NBP's ROE was at its highest in in the June 2019 quarter at 29.54%. The ROE was at its lowest in in the March 2019 quarter at -29.27%.

Quarterly (TTM)
Annual

Average

-9.64%

Median

-21.23%

Minimum

-85.31%

Maximum

99.48%

NovaBridge Biosciences (NBP) ROE by Quarter and Year

Discovering the peaks and valleys of NovaBridge Biosciences ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 73.04%

Maximum Annual ROE = 99.48%

Minimum Annual Increase = -707.27%

Minimum Annual ROE = -85.31%

Quarterly (TTM)
Annual
YearROEChange
2024-80.66%-5.45%
2023-85.31%2.35%
2022-83.35%64.00%
2021-50.82%-707.27%
20208.37%-88.53%
201972.98%73.04%
201842.18%-57.60%

NovaBridge Biosciences (NBP) Average ROE

How has NBP ROE performed in the past?

The current ROE of NovaBridge Biosciences (NBP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-83.10%

5-year avg

-58.35%

10-year avg

-9.64%

NovaBridge Biosciences (NBP) ROE vs. Peers

How is NBP’s ROE compared to its peers?

NovaBridge Biosciences’s ROE is less than Galectin Therapeutics Inc. (32.72%), greater than Design Therapeutics, Inc. (-27.15%), greater than DiaMedica Therapeutics Inc. (-78.98%), greater than Aura Biosciences, Inc. (-64.45%), greater than Rocket Pharmaceuticals, Inc. (-62.44%), greater than Annexon, Inc. (-70.04%), greater than Alpha Tau Medical Ltd. (-56.45%), less than LB Pharmaceuticals Inc Common Stock (97.81%), greater than enGene Holdings Inc. (-18.13%), greater than Altimmune, Inc. (-54.79%),

Build a custom stock screener for NovaBridge Biosciences (NBP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovaBridge Biosciences using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NovaBridge Biosciences (NBP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NovaBridge Biosciences or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is NovaBridge Biosciences's ROE?

How is the ROE calculated for NovaBridge Biosciences (NBP)?

What is the highest ROE for NovaBridge Biosciences (NBP)?

What is the 3-year average ROE for NovaBridge Biosciences (NBP)?

What is the 5-year average ROE for NovaBridge Biosciences (NBP)?

How does the current ROE for NovaBridge Biosciences (NBP) compare to its historical average?